|










| |
Oryx feature comparison chart
|
Feature |
OryxNano |
Oryx4 |
Oryx8 |
|
Vapor Diffusion
Drops |
 |
 |
 |
|
Vapor Diffusion
Multiple drops per reservoir single Protein |
 |
 |
 |
|
Vapor Diffusion
Multiple drops per reservoir 2 Proteins |
 |
 |
 |
|
Vapor Diffusion
Multiple drops per reservoir 3 Proteins |
 |
|
 |
|
Vapor Diffusion
Microseed Matrix Screening |
 |
 |
 |
|
Vapor Diffusion
Additive Experiments |
|
 |
 |
|
Microbatch
with automatic
oiling |
|
 |
 |
|
Microbatch
Additive experiments |
|
 |
 |
|
Microbatch
Microseed
Matrix Screening |
|
 |
 |
|
Optimization
|
|
|
 |
|
Microbatch 6D
optimization grids |
|
|
 |
|
Microbatch
optimization incomplete factorial designs
(7-channel) |
|
|
 |
|
Tools
|
|
Fluidigm Filling |
|
 |
 |
|
Price
|
|
GBP
|
£24,000
|
£33,000 |
£40,000 |
|
USD
|
US$45,800 |
US$63,000 |
US$75,600 |
The Major Differences
between Oryx8, Oryx4, OryxNano and the old Oryx 6 and IMPAX 1-5
-
Oryx8
is the flagship Douglas Instruments protein crystallization robot. It
can set up sitting drop nanodrops down to 100 + 100 nl. (The
reservoirs must be predispensed by some other method such as a 12-channel
pipette.) Standard additive and screening experiments are included.
Microbatch-under-oil screens can be set up (also down to 100 + 100 nl), as
well as optimization experiments using up to 7 ingredients with full pH
control. Optimization is mainly applied to microbatch, although
sitting drop can also be used by filling the reservoirs with a constant
solution.
-
Oryx4 is the
compact version of the product for those users who do not want to do
optimization. It produces vapor diffusion drops from pre-dispensed
reservoirs (including seeding and additive experiments) and it can do
microbatch-under-oil screening. Oryx4 can be upgraded to Oryx8 if
Optimization becomes a requirement.
-
OryxNano
is our latest robot designed specifically for sitting drop screening,
including seeding experiments. OryxNano does not do optimization or
(officially) microbatch. It is more affordable than
the other models and most, if not all, competitive offerings.
|